Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

C4 Therapeutics (CCCC) Prepaid Assets: 2019-2024

Historic Prepaid Assets for C4 Therapeutics (CCCC) over the last 6 years, with Dec 2024 value amounting to $9.8 million.

  • C4 Therapeutics' Prepaid Assets rose 16.45% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 16.45%. This contributed to the annual value of $9.8 million for FY2024, which is 70.98% up from last year.
  • Per C4 Therapeutics' latest filing, its Prepaid Assets stood at $9.8 million for FY2024, which was up 70.98% from $5.7 million recorded in FY2023.
  • In the past 5 years, C4 Therapeutics' Prepaid Assets ranged from a high of $10.7 million in FY2021 and a low of $4.8 million during FY2020.
  • In the last 3 years, C4 Therapeutics' Prepaid Assets had a median value of $9.8 million in 2024 and averaged $8.5 million.
  • As far as peak fluctuations go, C4 Therapeutics' Prepaid Assets spiked by 203.20% in 2020, and later plummeted by 42.51% in 2023.
  • Yearly analysis of 5 years shows C4 Therapeutics' Prepaid Assets stood at $4.8 million in 2020, then surged by 121.13% to $10.7 million in 2021, then declined by 7.13% to $9.9 million in 2022, then plummeted by 42.51% to $5.7 million in 2023, then surged by 70.98% to $9.8 million in 2024.